EAGLE ASSET MANAGEMENT INC - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 216 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2023. The put-call ratio across all filers is 2.45 and the average weighting 0.2%.

Quarter-by-quarter ownership
EAGLE ASSET MANAGEMENT INC ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q3 2023$10,501,855
-18.7%
209,117
+2.3%
0.06%
-13.9%
Q2 2023$12,917,132
+74.4%
204,385
+24.1%
0.07%
+67.4%
Q1 2023$7,406,000
-4.7%
164,636
-8.2%
0.04%
-10.4%
Q4 2022$7,769,000
-32.7%
179,436
+2.4%
0.05%
-36.0%
Q3 2022$11,549,000
+20.8%
175,282
-7.4%
0.08%
+25.0%
Q2 2022$9,557,000
-58.1%
189,216
-47.0%
0.06%
-48.7%
Q1 2022$22,807,000
-45.8%
357,029
-7.2%
0.12%
-36.8%
Q4 2021$42,097,000
+3.1%
384,627
-3.2%
0.18%
+0.5%
Q3 2021$40,839,000
+2.5%
397,229
-12.3%
0.18%
+7.6%
Q2 2021$39,835,000
-12.5%
452,885
-2.5%
0.17%
-15.3%
Q1 2021$45,508,000
-12.7%
464,614
-0.1%
0.20%
-31.3%
Q4 2020$52,148,000
+8.5%
464,986
-11.4%
0.29%
+19.0%
Q3 2020$48,050,000
+10.0%
524,740
-8.0%
0.25%
-0.4%
Q2 2020$43,671,000
+24.4%
570,497
-4.9%
0.25%
+13.8%
Q1 2020$35,094,000
-42.7%
600,104
-21.5%
0.22%
-25.9%
Q4 2019$61,250,000
+8.5%
764,580
-0.5%
0.29%
+1.0%
Q3 2019$56,449,000
-21.5%
768,328
+0.8%
0.29%
-20.9%
Q2 2019$71,896,000
+17.6%
762,178
-0.2%
0.37%
+12.9%
Q1 2019$61,150,000
+49.0%
763,908
+0.3%
0.33%
+26.4%
Q4 2018$41,040,000
-32.5%
761,269
-2.2%
0.26%
-12.2%
Q3 2018$60,783,000
+610.2%
778,683
+477.5%
0.29%
+539.1%
Q2 2018$8,559,000134,8420.05%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q3 2023
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 423,012$41,129,0007.43%
Eagle Health Investments LP 133,163$12,947,0005.08%
DAFNA Capital Management LLC 207,911$20,215,0004.80%
Casdin Capital, LLC 1,550,000$150,707,0004.49%
SIB LLC 65,151$6,335,0003.72%
CADIAN CAPITAL MANAGEMENT, LP 913,702$88,839,0003.29%
Integral Health Asset Management, LLC 117,500$11,425,0003.26%
Rock Springs Capital Management LP 746,732$72,605,0001.58%
Avidity Partners Management LP 546,000$53,088,0001.47%
Zebra Capital Management LLC 12,698$1,235,0001.36%
View complete list of BLUEPRINT MEDICINES CORP shareholders